No Data
The shareholding percentage of Wakamoto and Asset Value has increased to 8.54%.
It has been revealed that the shareholding ratio of Asset Value Investors (Asset Value) in Wakamoto <4512.T> has increased. According to the large shareholding change report submitted by Asset Value after the market closed on the 1st, the shareholding ratio rose from 7.45% at the time of the last submission to 8.54%. The purpose of the shareholding is to engage in pure investment and significant proposal activities, etc. The closing price on the 1st was 312 yen, down 5 yen from the previous day. Provided by Wealth Advisor Inc.
Express News | 【Change Report】Asset Value Investors Limited reported an increase in Shareholding in Wakamon Pharmaceuticals (4512.JP) to 8.54%.
Wakamoto Pharmaceutical To Go Ex-Dividend On March 28th, 2025 With 3 JPY Dividend Per Share
March 26th (Japan Standard Time) - $Wakamoto Pharmaceutical(4512.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 3 JPY dividend per share. The
Wakamoto Pharmaceutical: Notice regarding revisions to dividend forecasts
Wakamoat Pharmaceutical Issues FY Dividend Plan at Y3.00
Renascience ETC [Stocks with allure seen from Volume changes]
Stock closing prices compared to the previous day Volume *<2480>* Sysloco 1,494,244,217,300 *<7235>* Toh Radiator 987,112,881,000 *<4512>* Wakamoto 319,165,211,200 *<3538>* Will Plus H 994,215,6600 *<4889>* Renascience 124,613,068,61800 *<130A>* VIS 860,406,7900 *<7214>* GMB 958,311,03500 *<302A>* B-Style HD 150,015,93910
